Live data·just now
Surveillance
Signal overview
System-level view of disproportionality, emerging risk, and supporting literature.
Drug–event pairs
3,926,119
576,127 of 2,533,164 evaluable
High-priority signals
92
composite ranking
Largest QoQ rise
Potassium Chloride
+433%Toxic Anterior Segment Syndrome
FAERS reports indexed
17.2M
2012Q4..2026Q1
Literature retrievals
532
PubMed evidence
Signal landscape
Disproportionality vs. report volume. Bubble size = seriousness rate; teal = flagged.
scroll to zoom · drag to pan
Priority queue
Top composite-ranked emerging signals.
Latest literature
Highest-relevance PubMed retrievals.
A Descriptive Analysis from VigiAccess on Drug-related Problems Associated with the Glucagon-like Peptide-1 Receptor Agonists.
Analysis of tirzepatide in the US FDA adverse event reporting system (FAERS): a focus on overall patient population and sex-specific subgroups.
A real-world data analysis of tirzepatide in the FDA adverse event reporting system (FAERS) database.